PARTICIPATING SITES TO DATE:
170

Current Data Reports

COLLABORATION IS OUR STRATEGY.
​CHILDREN ARE OUR PRIORITY.

---

As the novel coronavirus (Covid-19) pandemic continues,
understanding the epidemiology of the new virus will be crucial
for developing effective prevention and treatment strategies.
The COVID-19 clinical presentation is poorly defined in pediatric populations, as most of the reported known cases are adults. We aim to describe the epidemiology, clinical presentation, management, and outcomes associated with COVID-19 ​among pediatric patients across
​the United States of America. ​​

CASES SUBMITTED:
11,884
HOSPITAL ADMITS:
1523
ICU ADMISSIONS:
555
DEATHS:
21
(AS OF 5/7/2021, 9:00 AM CST)

WHO CAN SUBMIT A CASE?

---

​Anyone with a pediatric (< 21 years old) patient diagnosed with Covid-19 at their institution. Cases can be outpatient or hospitalized. Respondents will enter case information using secondary data originally collected for standard of care.
We do not collect PHI.

Do you know of a center potentially​interested in participating?
​Share our page!​

REFER A SITE

CASES UPDATED EACH DAY

As this pandemic evolves we will continue to provide high level data with hopes of more granular data in the future.

CURRENT DATA

STAY UP TO DATE

​March 29th, 2021 - The Registry will be updating its eligibility and accrual closure as of May 1st. Cases diagnosed with COVID-19 on or after May 1, 2021, will not be eligible for the registry. You will still be able to submit cases diagnosed on or before April 30, 2021 

November 10th, 2020 - The REDCap server will undergo an update, and there will be an outage for approximately 2 hours. The system will be down from 5PM until 7 PM CST on November 10th, 2020.

We Work Together For the Kids

---

---

PIDTRAN (Pediatric Infectious Diseases Transplant Network) is collaborating with pediatric centers across the United States to learn more about COVID-19. We are stronger together, and look forwarding to working with you!
​Thank you for contributing to this endeavor and furthering our understanding of COVID-19 among pediatric patients.